OKUR OnKure Therapeutics, Inc.
$3.10▼ -5.20%
Healthcare
Other
After hours
$3.10▲ +0.00%
Sep 11, 7:30 PM ET
Volume 253.6K
Avg Volume (10D) 161.3K
Key Metrics & Fundamentals
Market Cap
$125.54M
P/E Ratio
–
Div Yield
–%
52W Range
2.23 - 5.38
% vs 50 MA
-22.24%
% vs 200 MA
-15.65%
RSI-14
20.8
MACD Histogram
-0.0500
Beta (1Y vs SPY)
1.23
Free Cash Flow
-$10.36M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$16.71M
COGS
–
Operating Exp
$16.90M
Operating Income
-$16.90M
EBIT
-$16.90M
Pretax Income
-$15.35M
Net Income
-$15.35M
EPS (Diluted)
-0.31
Price & Volume History
Loading chart…
Recent News
OnKure Therapeutics to Participate in the Morgan Stanley Global Healthcare Conference
GlobeNewswire · Aug 31, 2026 12:00 PM
OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
GlobeNewswire · Aug 4, 2026 8:05 PM
OnKure Therapeutics Spotlights Allosteric PI3Kα Drugs as 2027 IND Targets Near
MarketBeat · Jul 15, 2026 5:02 PM
OnKure Therapeutics to Host Virtual KOL Event to Discuss PI3Kα Inhibitor Medicines: Selectivity Matters & Pan-Mutant Allosteric Inhibition Delivers, on July 15, 2026
GlobeNewswire · Jul 2, 2026 12:00 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See OKUR's money flow as a full page
Social Sentiment
Avg +0.60 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.